Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$811,148
+$42,004 QoQ
Shares Held
2,240
+2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,838
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Forvis Mazars Wealth Advisors, LLC holds $83,206,945 across 10 Drug Manufacturers - General names. AMGN ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
42,430 | $50,891,819 | |
| 2 | JNJ |
Johnson & Johnson
|
56,938 | $14,460,543 | |
| 3 | ABBV |
AbbVie Inc.
|
28,316 | $7,125,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,526 | $6,364,091 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
25,031 | $1,442,286 | |
| 6 | PFE |
Pfizer Inc
|
44,567 | $1,073,173 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,240 | $811,148 | |
| 8 | AZN |
Astrazeneca PLC
|
2,202 | $417,543 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $811,148 | 2,240 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $769,144 | 2,186 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $713,863 | 2,181 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $661,759 | 2,345 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $577,964 | 2,070 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $642,104 | 2,061 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $609,115 | 2,337 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $768,793 | 2,386 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $532,727 | 1,705 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $662,181 | 2,329 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $742,515 | 2,578 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $683,456 | 2,543 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $424,502 | 1,912 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $334,582 | 1,384 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $349,573 | 1,331 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $281,073 | 1,247 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $337,943 | 1,389 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $295,987 | 1,224 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $213,271 | 948 | Shares | Sole | 2022-01-14 | |
| 2021-03-31 | $340,372 | 1,368 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,163,395 | 5,060 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $1,173,456 | 4,617 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,051,935 | 4,460 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $883,902 | 4,360 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||